CC vs. GH

Last updated Apr 1, 2026

Compare and contrast key facts about The Chemours Company (CC) and Guardant Health, Inc. (GH).

Performance

CC vs. GH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Chemours Company (CC) and Guardant Health, Inc. (GH). The values are adjusted to include any dividend payments, if applicable.

CC vs. GH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
CC The Chemours Company	87.80%	-27.57%	-44.01%	6.53%	-5.99%	39.85%	45.61%	-32.54%	-30.46%
GH Guardant Health, Inc.	-9.57%	234.34%	12.94%	-0.55%	-72.81%	-22.39%	64.93%	107.87%	16.74%

Fundamentals

Market Cap CC : $3.32B GH : $11.88B
EPS CC : -$2.47 GH : -$3.30
PS Ratio CC : 0.74 GH : 11.85
Total Revenue (TTM) CC : $4.48B GH : $982.02M
Gross Profit (TTM) CC : $749.00M GH : $633.01M
EBITDA (TTM) CC : $504.00M GH : -$375.72M

Returns By Period

In the year-to-date period, CC achieves a 87.80% return, which is significantly higher than GH's -9.57% return.

CC

• 1D: 3.92%
• 1M: 20.78%
• YTD: 87.80%
• 6M: 40.79%
• 1Y: 67.11%
• 3Y*: -6.26%
• 5Y*: -1.47%
• 10Y*: 15.13%

GH

• 1D: 7.16%
• 1M: -1.63%
• YTD: -9.57%
• 6M: 47.84%
• 1Y: 116.83%
• 3Y*: 57.95%
• 5Y*: -10.06%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CC vs. GH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CC

CC Risk / Return Rank: 72
CC Sharpe Ratio Rank: 74
CC Sortino Ratio Rank: 72
CC Omega Ratio Rank: 69
CC Calmar Ratio Rank: 73
CC Martin Ratio Rank: 71

GH

GH Risk / Return Rank: 90
GH Sharpe Ratio Rank: 91
GH Sortino Ratio Rank: 91
GH Omega Ratio Rank: 88
GH Calmar Ratio Rank: 91
GH Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CC vs. GH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Chemours Company (CC) and Guardant Health, Inc. (GH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CC	GH	Difference
Sharpe ratio Return per unit of total volatility	0.97	2.05	-1.09
Sortino ratio Return per unit of downside risk	1.68	2.91	-1.22
Omega ratio Gain probability vs. loss probability	1.21	1.36	-0.15
Calmar ratio Return relative to maximum drawdown	1.63	3.97	-2.34
Martin ratio Return relative to average drawdown	3.59	9.89	-6.30
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CC vs. GH - Sharpe Ratio Comparison

The current CC Sharpe Ratio is 0.97, which is lower than the GH Sharpe Ratio of 2.05. The chart below compares the historical Sharpe Ratios of CC and GH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CC	GH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.97	2.05	-1.09
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.03	-0.15	+0.12
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.26	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.10	0.22	-0.12

Correlation

The correlation between CC and GH is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CC vs. GH - Dividend Comparison

CC's dividend yield for the trailing twelve months is around 1.59%, while GH has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CC The Chemours Company	1.59%	4.35%	5.92%	3.17%	3.27%	2.98%	4.03%	5.53%	2.98%	0.24%	0.54%	10.82%
GH Guardant Health, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

CC vs. GH - Drawdown Comparison

The maximum CC drawdown since its inception was -86.15%, smaller than the maximum GH drawdown of -91.03%. Use the drawdown chart below to compare losses from any high point for CC and GH.

Drawdown Indicators

	CC	GH	Difference
Max Drawdown Largest peak-to-trough decline	-86.15%	-91.03%	+4.88%
Max Drawdown (1Y) Largest decline over 1 year	-39.79%	-28.73%	-11.06%
Max Drawdown (5Y) Largest decline over 5 years	-76.42%	-90.30%	+13.88%
Max Drawdown (10Y) Largest decline over 10 years	-86.15%	—	—
Current Drawdown Current decline from peak	-47.21%	-48.43%	+1.22%
Average Drawdown Average peak-to-trough decline	-40.92%	-51.83%	+10.91%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.05%	11.54%	+6.51%

Volatility

CC vs. GH - Volatility Comparison

The Chemours Company (CC) has a higher volatility of 19.61% compared to Guardant Health, Inc. (GH) at 12.82%. This indicates that CC's price experiences larger fluctuations and is considered to be riskier than GH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CC	GH	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.61%	12.82%	+6.79%
Volatility (6M) Calculated over the trailing 6-month period	46.34%	40.43%	+5.91%
Volatility (1Y) Calculated over the trailing 1-year period	69.73%	57.26%	+12.47%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	54.83%	67.05%	-12.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	57.38%	68.17%	-10.79%

Financials